673
Views
10
CrossRef citations to date
0
Altmetric
Review

The efficacy of intrauterine devices for emergency contraception and beyond: a systematic review update

&
Pages 471-479 | Published online: 21 Aug 2019

References

  • Shen J, Che Y, Showell E, et al. Interventions for emergency contraception. Cochrane Database Syst Rev. 2017;(8):Art. No.: CD001324. doi:10.1002/14651858.CD001324.pub5
  • Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod. 2012;27(7):1994–2000. doi:10.1093/humrep/des14022570193
  • Turok DK, Sanders JN, Thompson IS, Royer PA, Eggebroten J, Gawron LM. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study. Contraception. 2016;93:526–532. doi:10.1016/j.contraception.2016.01.00926944863
  • Armstrong C. ACOG Recommendations on Emergency Contraception. Am Fam Physician. 2010;82(100):1278.21121541
  • Trussell J, Schwarz EB. Emergency contraception In: Hatcher RA, Trussell J, Nelson A, Cates W, Stewart F, Kowal D, Polichar M, editors. Contraceptive Technology. New York, NY: Ardent Media; 2011; 113–145:
  • Turok DK, Godfrey EM, Wojdyla D, et al. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle. Hum Reprod. 2013;10(2):477–488.
  • Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998–2007. doi:10.1056/NEJMoa111085522621627
  • Harper CC, Speidel JJ, Drey EA, Trussell J, Blum M, Darney PD. Copper Intrauterine device for emergency contraception: clinical practice among contraceptive providers. Obstet Gynecol. 2012;119:220–226. doi:10.1097/AOG.0b013e3182429e0d22270272
  • Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.100009719621072
  • Sanders JN, Howell L, Saltzman HM, Schwarz EB, Thompson IS, Turok DK. Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception. Am J Obstet Gynecol. 2016;215(5):592e1.592.e5. doi:10.1016/j.ajog.2016.06.028
  • Royer PA, Turok DK, Sanders JN, et al. Choice of emergency contraceptive and decision making regarding subsequent unintended pregnancy. J Women’s Health. 2016;25:1038–1043. doi:10.1089/jwh.2015.5625
  • Sanders JN, Turok DK, Royer PA, Thompson IS, Gawron LM, Storck KE. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception. Contraception. 2017;96:99–105. doi:10.1016/j.contraception.2017.05.01228596121
  • Akintomide H, Vinayagam S, Schunmann C. Emergency intrauterine device insertion in teenagers: an informal retrospective study. J Famm Plann Reprod Health Care. 2014;40:196–199. doi:10.1136/jfprhc-2013-100813
  • Envall N, Groes Kofoed N, Kopp-Kallner H. Use of effective contraception 6 months after emergency contraception with a copper intrauterine device or ulipristal acetate-a prospective observational cohort study. Acta Obstet Gynecol Scand. 2016;95:887–893. doi:10.1111/aogs.1291627109900
  • Turok DK, Jacobsen JC, Dermish AI, et al. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates. Contraception. 2014;89:222–228. doi:10.1016/j.contraception.2013.11.01024332433
  • Mohammed ML. Acceptability and satisfaction towards Copper T 380A versus single dose levonorgestrel as emergency contraception among Egyptian women. Egypt J Fertil Steril. 2015;19:34–40.
  • Kohn JE, Nucatola DL. EC4U: results from a pilot project integrating the copper IUC into emergency contraceptive care. Contraception. 2016;94:48–51. doi:10.1016/j.contraception.2016.02.00826877186
  • Han Y. The clinical observation of the GyneFix IUD for emergency contraception. J Pract Obstet Gynecol. 2001;17:171–172. Chinese.
  • Wang C, Tiaan M, Shao M. A clinical comparative observation among copper IUD, low dose mifepristone and levonorgestrel for emergency contraception. J Chin Phys. 2000;2(5):271–273. Chinese.
  • Li J, Zhao M. Comparative effectiveness of three different methods of emergency contraception. J Guanxi Med Univ. 2016;33(2):308–309. Chinese.
  • Zhu C. Comparison of interval versus emergency IUD placement. China Health Care Nutr. 2013;23(4):1749–1750. Chinese.
  • He Y. Comparison of side effects of the copper IUD and LNG as emergency contraception. J Front Health. 2017;26(9):175 Chinese.
  • Mei X. Comparative analysis of the clinical effects of mifepristone, levonorgestrel and copper IUDs for emergency contraception. J Chin Med. 2017;15(19):97–98. Chinese.
  • Wu TL. Comparison of the side effects of copper IUD and mifepristone in emergency contraception. Henan Med Res. 2016;25(10):1835–1836. Chinese.
  • Wei M. Clinical efficacy of the copper containing IUD and mifepristone for emergency contraception. Chinese J Trauma Disability Med. 2016;24(5):68–69. Chinese.
  • Xu P. Clinical comparison of copper IUD and LNG in emergency contraception. Zhongwai Nuxing. 2016;11:184–186. Chinese.
  • Zhu Y. Four different methods for emergency contraception. Guide China Med. 2017;15(11):24–25. Chinese.
  • Tian Z. Mifipristone and copper IUD in emergency contraception. China Health Care Nutr. 2013;23(9):5238 Chinese.
  • Zhao Y, Wang Y. Copper Yuan-gong+indomethacin for emergency contraception in 26 cases. Health All. 2015;2:165 Chinese.
  • Dixon GW, Schlesselman JJ, Ory HW, et al. Ethinyl estradiol and conjugated estrogens as postcoital contraceptives. JAMA. 1980;244:1336–1339. doi:10.1001/jama.1980.033101200240166251288
  • Black TRL, Goldstuck ND, Spence A. Post-coital intrauterine device insertion—a further evaluation. Contraception. 1980;22:653–658. doi:10.1016/0010-7824(80)90090-67214912
  • Goldstuck ND. Clarification of the role of the Jaydess (Skyla) LNG-IUS 13.5 mg and Kyleena LNG-IUS 19.5 mg as intrauterine contraceptive systems. Expert Rev Med Devices. 2017;14(8):593–599. doi:10.1080/17434440.2017.135016928675069
  • Golstuck ND, Le HP. Delivery of progestins via the subdermal versus the intrauterine route: comparison of the pharmacology and clinical outcomes. Exp Opin Drug Deliv. 2018;15(7):717–727. doi:10.1080/17425247.2018.1498080
  • Brache V, Cochon L, Duikers IJ, et al. A prospective, randomised, pharmacodynamics study of quick-starting a desorgestrel progestin-only pill following ulipristal acetate for emergency contraception. Hum Reprod. 2015;30(12):2785–2793. doi:10.1093/humrep/dev24126405263
  • Wildemeersch D, Pett A, Jandi S, Hasskamp T, Rowe P, Vrijens M. Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices. Int J Women’s Health. 2013;5:215–225. doi:10.2147/IJWH23658502
  • Hsia JK, Creinin MD. Intrauterine contraception In: Hammond C editor. Innovations in Contraception Semin Reprod Med. Sacrimento. Thieme Medical Publishers, Sacramento, California, USA; 2016:2–9. doi:10.1055/s-0036-157438
  • Kubba AA, Guillebaud J. Failure of post-coital contraception after insertion of an intrauterine device. Case report. BJOG. 1984;91:596–597. doi:10.1111/j.1471-0528.1984.tb04810.x
  • Goldstuck. Failure of post-coital contraception after insertion of an intrauterine device. Case report. BJOG. 1985;92:107. doi:10.1111/j.1471-0528.1985.tb01058.x
  • Rowe P, Farley T, Peregoudov A, et al. Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A. Contraception. 2016;93:498–506. doi:10.1016/j.contraception.2016.02.02426916172